NSF award 2625904 · Arizona State University

FDT-BioTech: Composable Digital Twins for Clinical Trials Projections

Final report due

28 February 2030

in 1,229 days · The award ends on 31 October 2029.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

Decide about an extension3 Jul 2029in 989 days
award ending 2029-10-31 · Research.gov
This one is ours, not NSF’s.
Extension request16 Sep 2029in 1064 days
award ending 2029-10-31 · Research.gov
PAPPG 24-1: “at least 45 days prior to the end date”
No-cost extension notice21 Oct 2029in 1099 days
award ending 2029-10-31 · Research.gov
PAPPG 24-1: “at least ten calendar days prior to the end date”
Final report due28 Feb 2030in 1229 days
award ending 2029-10-31 · Research.gov
PAPPG 24-1: “no later than 120-days following the end date of the award”
Project outcomes report due28 Feb 2030in 1229 days
award ending 2029-10-31 · Research.gov
PAPPG 24-1: “no later than 120 days following the end date”
Award is closed out28 Feb 2030in 1229 days
award ending 2029-10-31 · Research.gov
PAPPG 24-1: “financially closed out 120 days after their expiration date”

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

NSF lists this award's end date as 31 October 2029.
NSF rules say the final report is due no later than 120 days after that.
So the final report is due by 28 February 2030.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number: 2625904
Period of support: 1 Nov 2026 – 31 Oct 2029
Amount: $799,999
Awardee: Arizona State University, Scottsdale, AZ
Program: MSPA-INTERDISCIPLINARY
Directorate: MPS

Abstract

Medical clinical trials often span many years, during which the standard of care continues to evolve. When physicians adopt new procedures alongside an experimental therapy or device, the final trial results may no longer reveal how much patient benefit arose from the intervention itself and how much resulted from changes in clinical practice. Because patients cannot ethically be denied improved care, this challenge…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.